The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after 2 or more HER2-directed chemotherapies (KM-10A/KCSG BR18-13).
 
Ju Won Kim
No Relationships to Disclose
 
Yeon Hee Park
Honoraria - AstraZeneca; Daiichi-Sankyo; Eisai; Gilead Sciences; Helsinn Healthcare; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boryung; Daiichi-Sankyo; Eisai; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Inocras (Inst); NGeneBio (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Gilad
 
Hee Kyung Ahn
No Relationships to Disclose
 
Jihong Bae
No Relationships to Disclose
 
Suk-Young Park
No Relationships to Disclose
 
Heejung Chae
No Relationships to Disclose
 
Jee Hyun Kim
Honoraria - Amgen; AstraZeneca; AstraZeneca; Lilly; Roche; Roche; Roche
Consulting or Advisory Role - Eisai; MSD; Roche; Roche; Yuhan
Research Funding - Eisai (Inst); Ono Pharmaceutical (Inst); Roche (Inst)
 
Kyung-Hun Lee
No Relationships to Disclose
 
Min Hwan Kim
No Relationships to Disclose
 
Kyoung Eun Lee
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
In Hae Park
No Relationships to Disclose
 
Joo Young Jung
No Relationships to Disclose
 
Jung Yoon Choi
No Relationships to Disclose
 
KyongHwa Park
Stock and Other Ownership Interests - iMBDx
Honoraria - Celltrion
Consulting or Advisory Role - AstraZeneca; Daichi Sankyo
Patents, Royalties, Other Intellectual Property - IP transfer fee
Expert Testimony - LegoChem Biosciences
 
KM-10A/KCSG BR18-13 Investigators' Group
No Relationships to Disclose